Diabetes Type 1 Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Diabetes Type 1 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

Diabetes Type 1
mylife Diabetes Care AG125 enrolled20 locationsNCT07048795
Recruiting

Disentangling the Effect of Brain Insulin Resistance on Brain Health

Diabetes Type 2Diabetes Type 1
Henrik Bo Wiberg Larsson150 enrolled3 locationsNCT07374705
Recruiting
Not Applicable

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

Diabetes Type 1
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète35 enrolled5 locationsNCT06985862
Recruiting
Phase 2

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

Diabetes Mellitus, Type 1Presymptomatic Diabetes Type 1 (Stage 1)Diabetes Mellitus, Type I
PolTREG S.A.150 enrolled8 locationsNCT06688331
Recruiting
Not Applicable

Diabetes Intervention Involving Person-centred Nutritional Education

Diabetes Type 1
Umeå University54 enrolled1 locationNCT07258758
Recruiting
Not Applicable

Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)

Diabetes Type 1
Guy's and St Thomas' NHS Foundation Trust110 enrolled3 locationsNCT07193446
Recruiting
Not Applicable

Multicenter Study Evaluating the Relationship Between Perceived Daily Stress Level and Glycemic Level in Subjects With Type 1 Diabetes

Diabetes Type 1
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète125 enrolled14 locationsNCT06896045
Recruiting
Not Applicable

EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation

Diabetes Type 1Diabetes Type 2 on InsulinPancreatogenous Diabetes
DiappyMed154 enrolled16 locationsNCT06738849
Recruiting

The MIND Study - Microangiopathy IN Diabetes

Diabetes Type 1
HJN Sverige AB/Neko Health400 enrolled1 locationNCT06989190
Recruiting
Phase 3

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Diabetes Type 1
McGill University Health Centre/Research Institute of the McGill University Health Centre36 enrolled1 locationNCT06894784
Recruiting

Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)

ProteomicsDiabetes Type 1Diabetic Peripheral Neuropathy
Aristotle University Of Thessaloniki50 enrolled1 locationNCT04257877